Motor Cortex Stimulation (CPB 0755, reviewed 2026-10-21)
Effective date
Not stated in the notice
Identified
Oct 28, 2026
Summary
Aetna's Clinical Policy Bulletin 0755 says Aetna considers motor cortex stimulation experimental, investigational, or unproven for the listed indications because its effectiveness has not been established. The listed indications include amyotrophic lateral sclerosis, autism spectrum disorder, cerebral palsy, chronic refractory pain, depression, dysphagia, Parkinson's disease, post-stroke aphasia, post-stroke hemiparesis, seizures, traumatic brain injury and obsessive compulsive disorder, and the bulletin says that list is not all-inclusive. The bulletin also lists CPT, HCPCS and ICD-10 codes that are not covered for the indications listed in the policy.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
01Billing team: For the indications this policy lists as experimental, investigational or unproven, do not bill motor cortex stimulation or the listed CPT and HCPCS codes as covered services, because the policy says these codes are not covered for those indications.
02Billing team: Compare each claim's diagnosis codes with the ICD-10 codes the policy lists as not covered for these indications, noting that the policy says that list is not all-inclusive.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.